https://www.selleckchem.com/pr....oducts/cetuximab.htm
37, p = 0.03). Similar results were yielded in the PP analysis. Low MIPI and R-DHAOx were independent favorable prognostic markers for both PFS (HR = 0.44, p = 0.035) and OS (HR = 0.36, p = 0.045). In vitro and in silico analyses confirmed that oxaliplatin has an anti-MCL cytotoxic effect that differs from that of other PD. R-DHAOx before ASCT provides better outcome in transplantation eligible young MCL patients.Despite advances in gene therapy allogeneic hematopoietic stem cell transplants (HSCT) remains the most effective way to cu
Curtir
Comentario
Compartilhar
